BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30461530)

  • 1. Oral corticosteroid-dependent asthma: current knowledge and future needs.
    Pavord ID
    Curr Opin Pulm Med; 2019 Jan; 25(1):51-58. PubMed ID: 30461530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways.
    Cataldo D; Louis R; Michils A; Peché R; Pilette C; Schleich F; Ninane V; Hanon S
    J Asthma; 2021 Apr; 58(4):448-458. PubMed ID: 31928102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics for oral corticosteroid-dependent asthma.
    Yılmaz İ
    Allergy Asthma Proc; 2020 May; 41(3):151-157. PubMed ID: 32375958
    [No Abstract]   [Full Text] [Related]  

  • 5. Rational oral corticosteroid use in adult severe asthma: A narrative review.
    Chung LP; Upham JW; Bardin PG; Hew M
    Respirology; 2020 Feb; 25(2):161-172. PubMed ID: 31713955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma.
    Nguyen VQ; Ulrik CS
    Allergy Asthma Proc; 2016 Nov; 37(6):125-139. PubMed ID: 27931289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma.
    Ververeli K; Chipps B
    Ann Allergy Asthma Immunol; 2004 May; 92(5):512-22. PubMed ID: 15191019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to prevent exacerbations of childhood asthma.
    Peloza DL; Jackson DJ
    Curr Opin Pulm Med; 2019 Jan; 25(1):27-33. PubMed ID: 30422897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.
    Siergiejko Z; Świebocka E; Smith N; Peckitt C; Leo J; Peachey G; Maykut R
    Curr Med Res Opin; 2011 Nov; 27(11):2223-8. PubMed ID: 21933100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab for asthma in adults and children.
    Normansell R; Walker S; Milan SJ; Walters EH; Nair P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies.
    Abuan T; Yeager M; Montgomery AB
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):381-8. PubMed ID: 20958143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perception of oral corticosteroids in adult patients with asthma in France.
    Jaffuel D; Fabry-Vendrand C; Darnal E; Wilczynski O; Pain E; Bourdin A
    J Asthma; 2021 Jul; 58(7):946-957. PubMed ID: 32285714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use.
    Zazzali JL; Broder MS; Omachi TA; Chang E; Sun GH; Raimundo K
    Allergy Asthma Proc; 2015; 36(4):268-74. PubMed ID: 26108084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence.
    Calzetta L; Aiello M; Frizzelli A; Bertorelli G; Rogliani P; Chetta A
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of oral corticosteroids for severe asthma.
    Ramsahai JM; Wark PA
    Med J Aust; 2018 Jul; 209(S2):S18-S21. PubMed ID: 30453868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of oral corticosteroids in the treatment of acute wheezing episodes in asthmatic preschoolers: Systematic review with meta-analysis.
    Castro-Rodriguez JA; Beckhaus AA; Forno E
    Pediatr Pulmonol; 2016 Aug; 51(8):868-76. PubMed ID: 27074244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype.
    Al Efraij K; FitzGerald JM
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):669-676. PubMed ID: 29972739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in inhaled corticosteroid pharmacology.
    Zitt MJ
    Allergy Asthma Proc; 2007; 28(2):114-24. PubMed ID: 17479594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies.
    Casale TB; Burnette A; Bourdin A; Howarth P; Hahn B; Stach-Klysh A; Khurana S
    Ther Adv Respir Dis; 2022; 16():17534666221107313. PubMed ID: 35972211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma.
    Gurnell M; Heaney LG; Price D; Menzies-Gow A
    J Intern Med; 2021 Aug; 290(2):240-256. PubMed ID: 33598993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.